ストックスクリーナーアプリを入手
5.68
2.16%
0.12
前日終値:
$5.56
開ける：
$5.56
24時間の取引高:
966.71K
Relative Volume:
0.67
時価総額：
$790.23M
収益：
$62.04M
当期純損益:
$-533.34M
株価収益率:
-1.449
EPS:
-3.92
ネットキャッシュフロー:
$-473.07M
1週間 パフォーマンス:
+0.89%
1か月 パフォーマンス:
-9.41%
6か月 パフォーマンス:
+25.94%
1年 パフォーマンス:
-18.27%
1日の値動き範囲:
$5.47
$5.785
1週間の範囲:
$5.32
$5.785
52週間の値動き範囲:
$4.155
$14.45
Vir Biotechnology Inc Stock (VIR) Company Profile
名前
Vir Biotechnology Inc
セクター
電話
415-906-4324
住所
1800 OWENS STREET, SAN FRANCISCO, CA
VIR を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
VIR
Vir Biotechnology Inc
|
5.68 | 773.54M | 62.04M | -533.34M | -473.07M | -3.92 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.76 | 107.15B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
755.90 | 77.46B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
436.38 | 58.90B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
918.92 | 56.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
198.76 | 42.58B | 447.02M | -1.18B | -906.14M | -6.1812 |
Vir Biotechnology Inc Stock (VIR) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-09-03 | 開始されました | Evercore ISI | Outperform |
| 2025-08-27 | アップグレード | BofA Securities | Neutral → Buy |
| 2024-01-29 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2023-09-08 | ダウングレード | BofA Securities | Buy → Neutral |
| 2023-03-06 | アップグレード | JP Morgan | Neutral → Overweight |
| 2023-02-21 | アップグレード | Goldman | Neutral → Buy |
| 2023-01-27 | アップグレード | Morgan Stanley | Underweight → Equal-Weight |
| 2022-09-14 | 開始されました | SVB Leerink | Outperform |
| 2022-09-09 | 開始されました | Morgan Stanley | Underweight |
| 2022-03-03 | アップグレード | Robert W. Baird | Underperform → Neutral |
| 2021-12-21 | ダウングレード | Robert W. Baird | Neutral → Underperform |
| 2021-10-25 | アップグレード | JP Morgan | Underweight → Neutral |
| 2021-09-22 | ダウングレード | Goldman | Buy → Neutral |
| 2021-06-04 | 再開されました | Robert W. Baird | Neutral |
| 2021-01-27 | ダウングレード | JP Morgan | Neutral → Underweight |
| 2021-01-20 | 繰り返されました | H.C. Wainwright | Buy |
| 2020-10-05 | 開始されました | BofA Securities | Buy |
| 2020-09-14 | アップグレード | Goldman | Neutral → Buy |
| 2020-09-11 | アップグレード | JP Morgan | Underweight → Neutral |
| 2020-08-20 | 開始されました | Needham | Buy |
| 2020-03-19 | ダウングレード | JP Morgan | Neutral → Underweight |
| 2020-03-13 | ダウングレード | Goldman | Buy → Neutral |
| 2020-02-27 | ダウングレード | Robert W. Baird | Neutral → Underperform |
| 2020-02-04 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2019-11-14 | 開始されました | Robert W. Baird | Neutral |
| 2019-11-05 | 開始されました | Barclays | Overweight |
| 2019-11-05 | 開始されました | Cowen | Outperform |
| 2019-11-05 | 開始されました | Goldman | Buy |
| 2019-11-05 | 開始されました | JP Morgan | Overweight |
すべてを表示
Vir Biotechnology Inc (VIR) 最新ニュース
H.C. Wainwright Keeps Their Buy Rating on Vir Biotechnology (VIR) - The Globe and Mail
How to manage a losing position in Vir Biotechnology Inc.Weekly Stock Report & AI Enhanced Trade Execution Alerts - newser.com
Is Vir Biotechnology Inc. stock gaining market shareRisk Management & Long Hold Capital Preservation Tips - newser.com
Vir Biotechnology to Participate in the 8th Annual Evercore Healthcare Conference - BioSpace
How Vir Biotechnology Inc. stock reacts to job market dataWeekly Trade Analysis & Consistent Income Trade Ideas - newser.com
What margin trends mean for Vir Biotechnology Inc. stockMarket Trend Summary & Entry Point Confirmation Alerts - newser.com
Vir Biotechnology (NASDAQ:VIR) CFO Sells $37,802.44 in Stock - MarketBeat
Will Vir Biotechnology Inc. stock deliver consistent dividendsTrade Volume Summary & High Win Rate Trade Alerts - newser.com
Why Vir Biotechnology Inc. stock is favored by top institutionsJuly 2025 Momentum & Reliable Intraday Trade Alerts - newser.com
What to do if you’re stuck in Vir Biotechnology Inc.Market Trend Summary & Daily Stock Trend Reports - newser.com
How Vir Biotechnology Inc. stock reacts to oil pricesWeekly Volume Report & Target Return Focused Picks - newser.com
Vir Biotechnology EVP O’Byrne sells $37,782 in shares By Investing.com - Investing.com Australia
Vir Biotechnology EVP O’Byrne sells $37,782 in shares - Investing.com
[Form 4] Vir Biotechnology, Inc. Insider Trading Activity - Stock Titan
Vir Biotechnology EVP & CFO Jason O'Byrne Sells Shares - TradingView
CFO O'Byrne Surrenders 6,799 Of Vir Biotechnology Inc [VIR] - TradingView
Vir Biotechnology at Jefferies Conference: Advancing in Oncology and Infectious Diseases - Investing.com Canada
Risk adjusted return profile for Vir Biotechnology Inc. analyzedChart Signals & Verified Technical Signals - newser.com
Vir Biotechnology Stock Set For Premarket Surge? Retail Trader Hopes Swell As ‘Phenomenal’ HDV Data Sets Stage For Gilead Showdown - MSN
CFO O'Byrne Files To Sell 6,799 Of Vir Biotechnology Inc [VIR] - TradingView
Is Vir Biotechnology Inc. forming a reversal patternPortfolio Update Report & Proven Capital Preservation Methods - newser.com
Is it too late to sell Vir Biotechnology Inc.2025 Trading Volume Trends & Daily Chart Pattern Signal Reports - newser.com
What analysts say about Vir Biotechnology Inc stockSupport Zone Identification & Rapid Portfolio Trading - earlytimes.in
Vir Biotechnology Inc. stock trendline breakdown2025 Earnings Impact & Reliable Trade Execution Plans - newser.com
Can technical indicators confirm Vir Biotechnology Inc.’s reversalRisk Management & Free Community Consensus Stock Picks - newser.com
Visualizing Vir Biotechnology Inc. stock with heatmapsJuly 2025 Closing Moves & Real-Time Buy Zone Alerts - newser.com
How to escape a deep drawdown in Vir Biotechnology Inc.Market Sentiment Review & Risk Controlled Daily Trade Plans - newser.com
What the charts say about Vir Biotechnology Inc. todayWeekly Profit Analysis & Community Verified Watchlist Alerts - newser.com
Best data tools to analyze Vir Biotechnology Inc. stock2025 Market Trends & Verified Trade Idea Suggestions - newser.com
Published on: 2025-11-13 12:49:36 - newser.com
Tools to monitor Vir Biotechnology Inc. recovery probabilityTrade Volume Report & Real-Time Buy Signal Alerts - newser.com
Vir Biotechnology, Inc. (VIR) Stock Forecasts - Yahoo Finance
Vir Biotechnology Inc (VIR) 財務データ
収益
当期純利益
現金流量
EPS
1.38%
1.42%
大文字化:
|
ボリューム (24 時間):